News

The Heart Rhythm Society, with the European Heart Rhythm Association, Asian-Pacific Heart Rhythm Society, and Latin-American Heart Rhythm Society is proud to announce the Second World Forum on Cardiac Implantable Electronic Devices Follow-up.

The new partnership is set to expand availability of a revolutionary new technology

-Alizea™ and Celea™ are the world’s longest-lasting pacemakers for their size on the market today1 -AlizeaTM and CeleaTM Pacemaker Systems feature AutoMRI™ Mode and Bluetooth®2 Connectivity

Irvine, CA, May 17, 2023 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech,i announced today Jasmina (Jass) Brooks as President, Biosense Webster. In this role,...

World’s First Device Combining CCM Therapy With an ICD in a Single Rechargeable Implant That Treats Both Heart Failure Symptoms and Sudden Cardiac Death

Pulse Biosciences, Inc. announced its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology will be featured in three presentations at the upcoming Heart Rhythm 2023 Annual Meeting in New Orleans, LA from May 19-21.

vMap’s use with ‘Unmappable’ Ventricular Tachycardia Ablation and Accurate Proof-of-Concept Mapping Using Outpatient 12-lead ECG Data to be Presented at the Heart Rhythm Society’s Annual Conference in New Orleans.

AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM

Data Presented at Heart Rhythm Conference Will Highlight Importance of High-Fidelity, Low-Noise ECG Signals